100 related articles for article (PubMed ID: 15485649)
1. ZAK re-programs atrial natriuretic factor expression and induces hypertrophic growth in H9c2 cardiomyoblast cells.
Huang CY; Chueh PJ; Tseng CT; Liu KY; Tsai HY; Kuo WW; Chou MY; Yang JJ
Biochem Biophys Res Commun; 2004 Nov; 324(3):973-80. PubMed ID: 15485649
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta induces the expression of ANF and hypertrophic growth in cultured cardiomyoblast cells through ZAK.
Huang CY; Kuo WW; Chueh PJ; Tseng CT; Chou MY; Yang JJ
Biochem Biophys Res Commun; 2004 Nov; 324(1):424-31. PubMed ID: 15465036
[TBL] [Abstract][Full Text] [Related]
3. ZAK induces cardiomyocyte hypertrophy and brain natriuretic peptide expression via p38/JNK signaling and GATA4/c-Jun transcriptional factor activation.
Hsieh YL; Tsai YL; Shibu MA; Su CC; Chung LC; Pai P; Kuo CH; Yeh YL; Viswanadha VP; Huang CY
Mol Cell Biochem; 2015 Jul; 405(1-2):1-9. PubMed ID: 25869677
[TBL] [Abstract][Full Text] [Related]
4. Mixed lineage kinase ZAK utilizing MKK7 and not MKK4 to activate the c-Jun N-terminal kinase and playing a role in the cell arrest.
Yang JJ
Biochem Biophys Res Commun; 2002 Sep; 297(1):105-10. PubMed ID: 12220515
[TBL] [Abstract][Full Text] [Related]
5. Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: roles of the NF-κB and MAPK signaling pathways.
Abdelhamid G; El-Kadi AO
Free Radic Biol Med; 2015 May; 82():1-12. PubMed ID: 25614461
[TBL] [Abstract][Full Text] [Related]
6. ZAK induces MMP-2 activity via JNK/p38 signals and reduces MMP-9 activity by increasing TIMP-1/2 expression in H9c2 cardiomyoblast cells.
Cheng YC; Kuo WW; Wu HC; Lai TY; Wu CH; Hwang JM; Wang WH; Tsai FJ; Yang JJ; Huang CY; Chu CH
Mol Cell Biochem; 2009 May; 325(1-2):69-77. PubMed ID: 19184368
[TBL] [Abstract][Full Text] [Related]
7. The MAP3K ZAK, a novel modulator of ERK-dependent migration, is upregulated in colorectal cancer.
Rey C; Faustin B; Mahouche I; Ruggieri R; Brulard C; Ichas F; Soubeyran I; Lartigue L; De Giorgi F
Oncogene; 2016 Jun; 35(24):3190-200. PubMed ID: 26522728
[TBL] [Abstract][Full Text] [Related]
8. ERβ targets ZAK and attenuates cellular hypertrophy via SUMO-1 modification in H9c2 cells.
Pai P; Shibu MA; Chang RL; Yang JJ; Su CC; Lai CH; Liao HE; Viswanadha VP; Kuo WW; Huang CY
J Cell Biochem; 2018 Sep; 119(9):7855-7864. PubMed ID: 29932238
[TBL] [Abstract][Full Text] [Related]
9. The small GTP-binding protein Rac1 induces cardiac myocyte hypertrophy through the activation of apoptosis signal-regulating kinase 1 and nuclear factor-kappa B.
Higuchi Y; Otsu K; Nishida K; Hirotani S; Nakayama H; Yamaguchi O; Hikoso S; Kashiwase K; Takeda T; Watanabe T; Mano T; Matsumura Y; Ueno H; Hori M
J Biol Chem; 2003 Jun; 278(23):20770-7. PubMed ID: 12672819
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy.
Tong YF; Wang Y; Ding YY; Li JM; Pan XC; Lu XL; Chen XH; Liu Y; Zhang HG
Cell Physiol Biochem; 2017; 42(4):1645-1656. PubMed ID: 28746924
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase and c-Jun NH2-terminal kinase mediate hypertrophic responses to prostaglandin F2alpha in cultured neonatal rat ventricular myocytes.
Adams JW; Sah VP; Henderson SA; Brown JH
Circ Res; 1998 Jul; 83(2):167-78. PubMed ID: 9686756
[TBL] [Abstract][Full Text] [Related]
12. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
[TBL] [Abstract][Full Text] [Related]
13. Reoxygenation after severe hypoxia induces cardiomyocyte hypertrophy in vitro: activation of CREB downstream of GSK3beta.
El Jamali A; Freund C; Rechner C; Scheidereit C; Dietz R; Bergmann MW
FASEB J; 2004 Jul; 18(10):1096-8. PubMed ID: 15155564
[TBL] [Abstract][Full Text] [Related]
14. Fisetin activates Hippo pathway and JNK/ERK/AP-1 signaling to inhibit proliferation and induce apoptosis of human osteosarcoma cells via ZAK overexpression.
Fu CY; Chen MC; Tseng YS; Chen MC; Zhou Z; Yang JJ; Lin YM; Viswanadha VP; Wang G; Huang CY
Environ Toxicol; 2019 Aug; 34(8):902-911. PubMed ID: 31044527
[TBL] [Abstract][Full Text] [Related]
15. Isoenzyme-specific protein kinase C and c-Jun N-terminal kinase activation by electrically stimulated contraction of neonatal rat ventricular myocytes.
Strait JB; Samarel AM
J Mol Cell Cardiol; 2000 Aug; 32(8):1553-66. PubMed ID: 10900180
[TBL] [Abstract][Full Text] [Related]
16. MAP kinase- and Rho-dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells.
Thorburn J; Xu S; Thorburn A
EMBO J; 1997 Apr; 16(8):1888-900. PubMed ID: 9155015
[TBL] [Abstract][Full Text] [Related]
17. Lead activates nuclear transcription factor-kappaB, activator protein-1, and amino-terminal c-Jun kinase in pheochromocytoma cells.
Ramesh GT; Manna SK; Aggarwal BB; Jadhav AL
Toxicol Appl Pharmacol; 1999 Mar; 155(3):280-6. PubMed ID: 10079214
[TBL] [Abstract][Full Text] [Related]
18. Identification of the ZAK-MKK4-JNK-TGFβ signaling pathway as a molecular target for novel synthetic iminoquinone anticancer compound BA-TPQ.
Chen D; Wang W; Qin JJ; Wang MH; Murugesan S; Nadkarni DH; Velu SE; Wang H; Zhang R
Curr Cancer Drug Targets; 2013 Jul; 13(6):651-60. PubMed ID: 23607596
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activation.
Lim JY; Park SJ; Hwang HY; Park EJ; Nam JH; Kim J; Park SI
J Mol Cell Cardiol; 2005 Oct; 39(4):627-36. PubMed ID: 16125722
[TBL] [Abstract][Full Text] [Related]
20. TAK1-TAB1 fusion protein: a novel constitutively active mitogen-activated protein kinase kinase kinase that stimulates AP-1 and NF-kappaB signaling pathways.
Sakurai H; Nishi A; Sato N; Mizukami J; Miyoshi H; Sugita T
Biochem Biophys Res Commun; 2002 Oct; 297(5):1277-81. PubMed ID: 12372426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
